Cargando…
Erratum: Stylopine: a potential natural metabolite to activate vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196444/ https://www.ncbi.nlm.nih.gov/pubmed/37214468 http://dx.doi.org/10.3389/fphar.2023.1213155 |
Ejemplares similares
-
Stylopine: A potential natural metabolite to activate vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy
por: Velayutham, Naveen Kumar, et al.
Publicado: (2023) -
2D, 3D-QSAR study and docking of vascular endothelial growth factor receptor 3 (VEGFR3) inhibitors for potential treatment of retinoblastoma
por: Ren, Rui, et al.
Publicado: (2023) -
Chamaejasmine B Induces the Anergy of Vascular Endothelial Cells to VEGFA Pro-angiogenic Signal by Autophagic Regulation of VEGFR2 in Breast Cancer
por: Li, Qi, et al.
Publicado: (2018) -
Vascular endothelial growth factor and its soluble receptors VEGFR-1 and VEGFR-2 in the serum of patients with systemic lupus erythematosus.
por: Robak, Ewa, et al.
Publicado: (2003) -
Efficient microbial production of stylopine using a Pichia pastoris expression system
por: Hori, Kentaro, et al.
Publicado: (2016)